Year-end Sale % OFF 
Abstract
Expression of Concern: The antidiabetic β3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin (Am J Clin Nutr 1992;55:237S-41S)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
